Cel-Sci
Cel-Sci Logo
About Cel-Sci
CEL-SCI Corp is a clinical-stage biotechnology company focused on the research and development of immunotherapy products for the treatment of cancer, autoimmune, and infectious diseases. Its lead product, Multikine, is an immunotherapy that has completed Phase III clinical trials for head and neck cancer. CEL-SCI is also developing the Ligand Epitope Antigen Presentation System (LEAPS), a patented technology aimed at stimulating the immune system to address a range of diseases, including rheumatoid arthritis. The company was founded in 1983 and is headquartered in Vienna, Virginia.
Address
8229 Boone Boulevard, Suite 802
Vienna, 22182
United States
Year founded
1983
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
